Cargando…
Cardiovascular Events and Long‐Term Risk of Sudden Death Among Stabilized Patients After Acute Coronary Syndrome: Insights From IMPROVE‐IT
BACKGROUND: Unlike patients with low ejection fraction after an acute coronary syndrome (ACS), little is known about the long‐term incidence and influence of cardiovascular events before sudden death among stabilized patients after ACS. METHODS AND RESULTS: A total of 18 144 patients stabilized with...
Autores principales: | Fordyce, Christopher B., Giugliano, Robert P., Cannon, Christopher P., Roe, Matthew T., Sharma, Abhinav, Page, Courtney, White, Jennifer A., Lokhnygina, Yuliya, Braunwald, Eugene, Blazing, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245817/ https://www.ncbi.nlm.nih.gov/pubmed/35112882 http://dx.doi.org/10.1161/JAHA.121.022733 |
Ejemplares similares
-
Impact of Ezetimibe on New‐Onset Diabetes: A Substudy of IMPROVE‐IT
por: Shah, Nishant P., et al.
Publicado: (2023) -
Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long‐Term Follow‐Up After Acute Coronary Syndromes
por: Fanaroff, Alexander C., et al.
Publicado: (2017) -
Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
por: Kato, Eri Toda, et al.
Publicado: (2017) -
Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo: Analysis From IMPROVE-IT
por: Giugliano, Robert P., et al.
Publicado: (2020) -
Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF‐TIMI 48 Trial
por: Eisen, Alon, et al.
Publicado: (2016)